Abstract P2-02-17: T-DM1 in HER2-negative metastatic breast cancer patients with HER2-amplified circulating tumor cells: Current status of the CirCe T-DM1 phase II trial
暂无分享,去创建一个
M. Espié | M. Bollet | G. Romieu | F. Bidard | J. Pierga | V. Diéras | W. Jacot | É. Luporsi | S. Armanet | F. Lerebours | A. Lortholary | N. Tubiana-Mathieu | H. Bourgeois | P. Cottu | V. Servent | N. Renaud | K. Baeten | S. Pelissier | Sébastien Armanet